-
公开(公告)号：KR1020050055937A
公开(公告)日：2005-06-14
申请号：KR1020030089000
申请日：2003-12-09
Applicant: 재단법인서울대학교산학협력재단
IPC: C12N5/16
CPC classification number: C12N15/8771 , A01K67/0273 , A01K2227/101 , A23L13/00 , A61D19/04 , C12N5/16 , C12N15/8509 , C12N2015/8518 , C12N2517/00
Abstract: 본 발명은 소의 프리온 (이하 PrP라 함) 아미노산 서열 중 179번째 글루타민이 아르기닌으로 및/또는 230번째 글루타민이 리신으로 치환된 PrP 변이체를 코딩하는 DNA가 도입된 소 유래 체세포 핵을 탈핵된 난자에 이식하여 형성된 소의 핵 이식란 및 이의 작제방법에 관한 것이다.
본 발명은 소의 PrP 아미노산 서열 중 179번째 글루타민이 아르기닌으로 및/또는 230번째 글루타민이 리신으로 치환된 PrP 변이체를 발현하는 것을 특징으로 하는 형질전환 복제 소 및 이의 생산방법에 관한 것이다.
추가로 본 발명은 상기 형질전환 복제 소로부터 유래된 정육(meat) 및 가공식품에 관한 것이다.-
公开(公告)号：KR1020050055926A
公开(公告)日：2005-06-14
申请号：KR1020030088987
申请日：2003-12-09
Applicant: 재단법인서울대학교산학협력재단
IPC: C12N5/16
CPC classification number: C12N5/16 , A01K67/0273 , A01K2227/101 , A61D19/04 , C12N15/8509 , C12N15/8771 , C12N2015/8518 , C12N2517/00
Abstract: 본 발명은 유전자 적중 및 도입 기술과 체세포 복제 기술을 접목한 특정 질병에 대하여 내성을 가진 형질전환 복제동물의 생산방법 및 이 방법에 의해 생산된 복제동물에 관한 것이다.
구체적으로, 본 발명의 광우병에 내성을 가지는 형질전환 복제 소의 생산방법은 소 유래의 체세포의 프리온을 코딩하는 유전자를 적중시켜 형질전환 체세포를 제작하고, 이를 소 유래의 탈핵 난자에 도입하여 프리온 유전자가 적중된 핵 이식란을 작제하여, 이를 대리모에 이식하여 광우병 내성 소를 생산하는 단계를 포함한다.
또한, 본 발명의 형질전환 핵 이식란 및 복제 소는 정상적인 프리온이 적중되어 광우병에 내성을 가지는 것을 특징으로 한다.-
公开(公告)号：KR1020050023483A
公开(公告)日：2005-03-10
申请号：KR1020030059730
申请日：2003-08-28
Applicant: 재단법인서울대학교산학협력재단
IPC: C12M3/10
Abstract: PURPOSE: An improved method of intracytoplasmic sperm injection is provided, thereby reducing the medium amount used, inhibiting damage of oocyte and inducing mechanical damage of the sperm head membrane, so that the fertilization success rate can be improved. CONSTITUTION: An injection pipette having the diameter which is larger than the maximum head diameter of sperms to be introduced into the oocyte cytoplasm and is smaller than the maximum tail diameter of sperms is used in the intracytoplasmic sperm injection(ICSI), wherein the end of the pipette has a plurality of spikes. The improved method of intracytoplasmic sperm injection comprises the steps of: collecting a sperm with the injection pipette; introducing the sperm into the oocyte cytoplasm; and recovering the injection pipette, wherein the sperm head is collected by the tip of the injection pipette.
Abstract translation: 目的：提供细胞质内精子注射的改进方法，减少使用的培养基，抑制卵母细胞的损伤，诱导精子头膜的机械损伤，从而提高受精成功率。 构成：在细胞质内精子注射（ICSI）中使用直径大于要引入卵母细胞的精子的最大头部直径并且小于精子的最大尾部直径的注射移液管，其中末端 移液管具有多个尖峰。 细胞质内精子注射的改进方法包括以下步骤：用注射移液管收集精子; 将精子引入卵母细胞质中; 并回收注射移液管，其中精子头被注射移液管的尖端收集。
-
公开(公告)号：KR1020040060348A
公开(公告)日：2004-07-06
申请号：KR1020020087129
申请日：2002-12-30
Applicant: 재단법인서울대학교산학협력재단
IPC: C12N5/07
CPC classification number: C12N5/0604 , A01K67/0273 , A01K2227/101 , A01K2227/106 , C12N15/8771 , C12N15/8776 , C12N2500/44 , C12N2501/998 , C12N2517/00
Abstract: PURPOSE: A medium composition and culture method for improving preimplantation development of clone embryo are provided, thereby effectively inhibiting apoptosis of blastomere to improve preimplantation development of clone embryo, thereby improving the production yield of health clone embryo. CONSTITUTION: The medium composition for in vitro culturing the nucleus transferring somatic cell for preparing clone embryo contains 1-25 micromole of antibiotics such as beta-mercaptoethanol, and 1-10 microgram/milliliter of an oxidized nitrogen removing factor such as hemoglobin. The method for in vitro culturing the clone embryo in the medium composition comprises the steps of: (a) in vitro culturing the nucleus transferring somatic cell in the in vitro culturing medium composition containing antibiotics; (b) transplanting the nucleus of the nucleus transferring somatic cell to a nucleus receiving egg of which genetic materials are removed to prepare somatic cell clone embryo; and (c) in vitro culturing the somatic cell clone embryo in the in vitro culturing medium composition containing antibiotics and oxidized nitrogen removing factor.
Abstract translation: 目的：提供一种改善克隆胚胎植入前发育的培养基和培养方法，有效抑制卵裂球细胞凋亡，改善克隆胚胎植入前的发育，提高了克隆胚胎的产量。 构成：用于体外培养转运体细胞以制备克隆胚胎的培养基组合物含有1-25微摩尔的抗生素如β-巯基乙醇和1-10微克/毫升的氧化除氮因子如血红蛋白。 在培养基组合物中体外培养克隆胚胎的方法包括以下步骤：（a）体外培养在含有抗生素的体外培养培养基组合物中转运体细胞的细胞核; （b）将转移体细胞的细胞核移植到接受蛋的细胞核，其中遗传物质被去除以制备体细胞克隆胚胎; 和（c）在含有抗生素和氧化除氮因子的体外培养培养基组合中体外培养体细胞克隆胚胎。
-
Patent Agency Ranking
公开(公告)号：KR1020040047313A
公开(公告)日：2004-06-05
申请号：KR1020020075471
申请日：2002-11-29
Applicant: 재단법인서울대학교산학협력재단
IPC: C12N5/16
CPC classification number: C12N15/8771 , A01K67/0273 , A01K2227/101 , A01K2267/01 , A61D19/04 , C12N15/8509 , C12N2015/8518 , C12N2510/00 , C12N2510/02 , C12N2517/02
Abstract: PURPOSE: Transgenic cloned cow producing human lactoferricin and a method for producing the same are provided, thereby economically and efficiently producing biological medicines from the cloned animals and easily obtaining human lactoferricin from the milk of cloned animals. CONSTITUTION: The method for producing the transgenic cloned cow producing human lactoferricin comprises the steps of: (a) preparing nucleus donor cells by transferring a gene encoding human lactoferricin to somatic cell lines collected from cow; (b) preparing matured nucleus recipient ova collected from cow by removing oocytes from nucleus recipient ova of cow and removing cytoplasm including the first polar body; and (c) transferring the nucleus donor cells to the matured nucleus recipient ova and fusing them, wherein the somatic cells are collected from matured cow; and the nucleus transplanted ovum is SNU-B2(KCTC 10355BP).
Abstract translation: 目的：提供转基因克隆牛产生人乳铁蛋白及其生产方法，从而从克隆的动物中经济有效地生产生物药物，并且容易地从克隆动物的乳中获得人乳铁蛋白。 构成：生产人乳铁蛋白的转基因克隆牛的方法包括以下步骤：（a）通过将编码人乳铁蛋白的基因转移到从母牛收集的体细胞系中来制备核供体细胞; （b）通过从牛的核受体卵中除去卵母细胞并除去包括第一极体的细胞质来制备从牛采集的成熟的细胞核受体ova; 和（c）将核供体细胞转移到成熟的细胞核受体ova并使其融合，其中从成熟的牛收集体细胞; 移植的卵细胞为SNU-B2（KCTC 10355BP）。
-
公开(公告)号：KR101141733B1
公开(公告)日：2012-05-03
申请号：KR1020030088987
申请日：2003-12-09
Applicant: 재단법인서울대학교산학협력재단
IPC: C12N5/16
Abstract: 본 발명은 유전자 적중 및 도입 기술과 체세포 복제 기술을 접목한 특정 질병에 대하여 내성을 가진 형질전환 복제동물의 생산방법 및 이 방법에 의해 생산된 복제동물에 관한 것이다.
구체적으로, 본 발명의 광우병에 내성을 가지는 형질전환 복제 소의 생산방법은 소 유래의 체세포의 프리온을 코딩하는 유전자를 적중시켜 형질전환 체세포를 제작하고, 이를 소 유래의 탈핵 난자에 도입하여 프리온 유전자가 적중된 핵 이식란을 작제하여, 이를 대리모에 이식하여 광우병 내성 소를 생산하는 단계를 포함한다.
또한, 본 발명의 형질전환 핵 이식란 및 복제 소는 정상적인 프리온이 적중되어 광우병에 내성을 가지는 것을 특징으로 한다.
형질전환 복제소, 체세포 복제, 광우병, 프리온 유전자 적중, 광우병 내성-
公开(公告)号：KR100824218B1
公开(公告)日：2008-04-25
申请号：KR1020060128318
申请日：2006-12-15
Applicant: 재단법인서울대학교산학협력재단
Abstract: A method for producing a cloned wolf is provided to contribute to preserve a rare and endangered species wolf and develop veterinary medicine, anthropology and medicine study fields. A method for preparing a nuclear transplant embryo of wolf comprises the steps of: (a) removing a nucleus from ovum of a canine animal such as dog, wolf, fox, jackal, coyote, dhole, and raccoon dog to prepare a denucleated ovum; (b) isolating a somatic cell from a tissue of the wolf to prepare a donor nucleus cell; (c) micro-injecting the donor nucleus cell into the denucleated ovum and electrofusing it; and (d) activating the fused ovum. A nuclear transplant embryo prepared by the method is deposited as a deposition no. KCTC 10903BP. A method for producing a cloned wolf comprises a step of transplanting the nuclear transplant embryo into an oviduct of a canine animal surrogate mother. Further, the electrofusing step is performed at a voltage of 3.6 to 4.1 kv/cm, for 10 to 30 mus, 1 to 3 times.
Abstract translation: 提供了克隆狼的生产方法，有助于保护珍稀濒危物种狼，开发兽药，人类学和医学研究领域。 制备狼的核移植胚胎的方法包括以下步骤：（a）从狗，狼，狐狸，豺狼，土拨鼠，hole和浣熊犬等动物的卵中除去核，以制备脱核卵; （b）从狼的组织中分离体细胞以制备供体核细胞; （c）将供体核细胞微注射到去核的卵中并将其电铸; 和（d）激活融合的卵子。 通过该方法制备的核移植胚胎被沉积为沉积物。 KCTC 10903BP。 克隆的狼的制备方法包括将核移植胚胎移植到犬动物替代母亲的输卵管中的步骤。 此外，电熔步骤在3.6至4.1kv / cm的电压下进行10至30次，1至3次。
-
公开(公告)号：KR1020050022416A
公开(公告)日：2005-03-08
申请号：KR1020030060612
申请日：2003-08-30
Applicant: 재단법인서울대학교산학협력재단
IPC: C12N5/16
CPC classification number: C12N15/8778 , A01K67/0273 , A01K2227/108 , A01K2267/01 , A61D19/04 , C12N15/8509 , C12N2015/8518 , C12N2517/00
Abstract: PURPOSE: A transgenic cloned pig producing human erythropoietin and a method for producing the same transgenic cloned pig are provided, thereby producing a large quantity of human erythropoietin in the urinary bladder of the transgenic cloned pig with reduced costs. CONSTITUTION: The nuclear transfer embryo produced by a fusion of a pig-derived enucleated oocyte with a nucleus of a pig-derived somatic cell transfected and targeted with a gene encoding human erythropoietin is provided. The transgenic cloned pig expresses human erythropoietin in the urinary bladder of pig. The method for producing a transgenic cloned pig producing human erythropoietin comprises the steps of: (a) transfecting and targeting a gene encoding human erythropoietin into a pig-derived somatic cell line to prepare a nuclear donor cell; (b) removing cumulus cells surrounding a recipient oocyte and then the cytoplasm including the first polar body from the oocyte to prepare a pig-derived enucleated recipient oocyte; (c) transferring the transfected nuclear donor cell into the enucleated recipient oocyte and carrying out cell fusion to generate nuclear transfer embryos; and (d) transplanting the nuclear transfer embryo into a surrogate mother pig to produce live offspring.
Abstract translation: 目的：提供产生人促红细胞生成素的转基因克隆猪和产生相同转基因克隆猪的方法，从而以降低的成本在转基因克隆猪的膀胱中产生大量人促红细胞生成素。 构成：提供了通过将猪衍生的去核卵母细胞与转染并用编码人红细胞生成素的基因靶向的来源于体细胞的细胞核的融合产生的核转移胚。 转基因克隆猪在猪的膀胱中表达人促红细胞生成素。 生产人促红细胞生成素的转基因克隆猪的方法包括以下步骤：（a）将编码人促红细胞生成素的基因转染并靶向猪衍生的体细胞系以制备核供体细胞; （b）去除卵母细胞周围的卵丘细胞，然后从卵母细胞中除去包括第一极体的细胞质，以制备猪衍生的去核受体卵母细胞; （c）将转染的核供体细胞转移到去核的受体卵母细胞中并进行细胞融合以产生核转移胚胎; 和（d）将核转移胚胎移植到替代母猪中以产生活的后代。
-
公开(公告)号：KR1020040016426A
公开(公告)日：2004-02-21
申请号：KR1020030056629
申请日：2003-08-14
Applicant: 재단법인서울대학교산학협력재단
IPC: C12N5/16
CPC classification number: A01K67/0273 , A01K67/0275 , A01K2227/101 , A01K2267/01 , C12N9/6456 , C12N15/8509 , C12N15/8771 , C12N2830/008
Abstract: PURPOSE: A transgenic cloned cow producing human prourokinase and a method for producing the same are provided, thereby expressing human prourokinase from the mammary gland of the transgenic cloned cow, and easily separating it from milk. CONSTITUTION: Provided is a nucleus transplanted ovum wherein a nucleus of a somatic cell derived from a cow and containing a human prourokinase gene is fused with a nucleus removed ovum derived from cow. The nucleus transplanted ovum is SNU-B1(KCTC 10286BP). A method for producing the nucleus transplanted ovum comprises the steps of: (a) introducing a human prourokinase gene into the somatic cell derived from cow to prepare a nucleus transferring cell; (b) removing a cumulus cell and cytoplasm from a ovum of a cow to prepare a nucleus receiving ovum; and (c) transplanting the nucleus transferring cell into the nucleus receiving ovum and fusing them.
Abstract translation: 目的：提供产生人类原尿激酶的转基因克隆牛及其生产方法，从而从转基因克隆牛的乳腺中表达人类原尿激酶，并且容易地将它与牛分离。 构成：提供了一种移植卵的细胞核，其中源自牛的体细胞细胞核并含有人类原尿激酶基因与从牛获得的去除卵的细胞核融合。 移植的卵细胞为SNU-B1（KCTC 10286BP）。 用于产生移植卵的细胞的方法包括以下步骤：（a）将人类原尿激酶基因导入来自牛的体细胞，制备细胞核转移细胞; （b）从牛的卵中除去卵丘细胞和细胞质以制备接受卵的细胞核; 和（c）将细胞核转移细胞移植到接受卵子的细胞核中并融合它们。
-
-
-
-
-
-
-
-
Search Results
19
records
(took 0.03 seconds)
